BioToolsSpatial biology is transforming biomedical research by revealing the cellular architecture and microenvironments that shape health and disease. Spatial proteomic imaging adds unique functional context, enabling in situ protein mapping beyond the reach of genomics and transcriptomics alone. As the field advances, there's growing demand to scale beyond exploratory studies into high-throughput translational research.
Recent innovations in Imaging Mass CytometryTM (IMCTM) technology, including new acquisition modes - Tissue Mode, Preview Mode and Cell Mode - now support imaging over 100 slides per week with single-cell resolution, high dynamic range and easy assay development. Notably, the HyperionTM XTi Imaging System enables spatial proteomics on slides already processed for other modalities, such as Xenium or as H&Es, unlocking a powerful multi-omic view from a single tissue section. These advancements position the Hyperion XTi Imaging System as the premier platform for comprehensive, scalable spatial discovery.
登壇者
James Mansfield
Standard Biotools, VP of Business Development, Imaging
Jim is an accomplished scientist and business leader with over 25 years of experience in imaging and analysis technologies for the life sciences. He began his career with pioneering work in in-situ immune cell phenotyping. He holds seven patents, has authored more than 60 publications, serves on the editorial boards of two journals, and has received three industry awards. Jim is passionate about advancing multiplex pathology, particularly cancer immunotherapy and other clinical applications.
対象者
アカデミアの研究者、イメージング・空間プロテオミクス解析に興味のある方
主催
スタンダード・バイオツールズ株式会社
お問い合わせ先
japan-marketing@standardbio.com
マーケティングイベント担当
